Yingzi Pan

Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–2020

Qianhui Wu, Hongjie Yu, D. Rosillon, 2023, Human vaccines & immunotherapeutics.